These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 22858041)
1. The economic benefits of cell salvage in obstetric haemorrhage. Brearton C; Bhalla A; Mallaiah S; Barclay P Int J Obstet Anesth; 2012 Oct; 21(4):329-33. PubMed ID: 22858041 [TBL] [Abstract][Full Text] [Related]
2. A cost study of postoperative cell salvage in the setting of elective primary hip and knee arthroplasty. Rao VK; Dyga R; Bartels C; Waters JH Transfusion; 2012 Aug; 52(8):1750-60. PubMed ID: 22339139 [TBL] [Abstract][Full Text] [Related]
3. The use of cell salvage in routine cardiac surgery is ineffective and not cost-effective and should be reserved for selected cases. Attaran S; McIlroy D; Fabri BM; Pullan MD Interact Cardiovasc Thorac Surg; 2011 May; 12(5):824-6. PubMed ID: 21297148 [TBL] [Abstract][Full Text] [Related]
4. The volume of returned red blood cells in a large blood salvage program: where does it all go? Waters JH; Dyga RM; Waters JF; Yazer MH Transfusion; 2011 Oct; 51(10):2126-32. PubMed ID: 21985047 [TBL] [Abstract][Full Text] [Related]
6. The economic benefits of cell salvage in obstetric haemorrhage. Jaffer M; Swanton R; Wilson J Int J Obstet Anesth; 2013 Jul; 22(3):256. PubMed ID: 23702183 [No Abstract] [Full Text] [Related]
7. Relative cost of autologous red cell salvage versus allogeneic red cell transfusion during abdominal aortic aneurysm repair. Gardner A; Gibbs N; Evans C; Bell R Anaesth Intensive Care; 2000 Dec; 28(6):646-9. PubMed ID: 11153290 [TBL] [Abstract][Full Text] [Related]
8. The economic benefits of cell salvage in obstetric haemorrhage. In reply. Mallaiah S; Bhalla A; Barclay P; Brearton C Int J Obstet Anesth; 2013 Jul; 22(3):257. PubMed ID: 23706835 [No Abstract] [Full Text] [Related]
9. The Association of Targeted Cell Salvage Blood Transfusion During Cesarean Delivery With Allogeneic Packed Red Blood Cell Transfusions in a Maternity Hospital in China. Yan H; Hu LQ; Wu Y; Fan Q; Wong CA; McCarthy RJ Anesth Analg; 2018 Sep; 127(3):706-713. PubMed ID: 29505447 [TBL] [Abstract][Full Text] [Related]
10. Intraoperative salvage in patients undergoing elective abdominal aortic aneurysm repair: an analysis of cost and benefit. Goodnough LT; Monk TG; Sicard G; Satterfield SA; Allen B; Anderson CB; Thompson RW; Flye W; Martin K J Vasc Surg; 1996 Aug; 24(2):213-8. PubMed ID: 8752031 [TBL] [Abstract][Full Text] [Related]
11. Patient blood management in elective total hip- and knee-replacement surgery (part 2): a randomized controlled trial on blood salvage as transfusion alternative using a restrictive transfusion policy in patients with a preoperative hemoglobin above 13 g/dl. So-Osman C; Nelissen RG; Koopman-van Gemert AW; Kluyver E; Pöll RG; Onstenk R; Van Hilten JA; Jansen-Werkhoven TM; van den Hout WB; Brand R; Brand A Anesthesiology; 2014 Apr; 120(4):852-60. PubMed ID: 24434302 [TBL] [Abstract][Full Text] [Related]
12. The use of blood cell salvage in acetabular fracture internal fixation surgery. Bigsby E; Acharya MR; Ward AJ; Chesser TJ J Orthop Trauma; 2013 Oct; 27(10):e230-3. PubMed ID: 23360908 [TBL] [Abstract][Full Text] [Related]
13. Patient blood management in elective total hip- and knee-replacement surgery (Part 1): a randomized controlled trial on erythropoietin and blood salvage as transfusion alternatives using a restrictive transfusion policy in erythropoietin-eligible patients. So-Osman C; Nelissen RG; Koopman-van Gemert AW; Kluyver E; Pöll RG; Onstenk R; Van Hilten JA; Jansen-Werkhoven TM; van den Hout WB; Brand R; Brand A Anesthesiology; 2014 Apr; 120(4):839-51. PubMed ID: 24424070 [TBL] [Abstract][Full Text] [Related]
14. Autologous blood transfusion during emergency trauma operations. Brown CV; Foulkrod KH; Sadler HT; Richards EK; Biggan DP; Czysz C; Manuel T Arch Surg; 2010 Jul; 145(7):690-4. PubMed ID: 20644133 [TBL] [Abstract][Full Text] [Related]
15. Autologous blood salvage in the era of patient blood management. Sikorski RA; Rizkalla NA; Yang WW; Frank SM Vox Sang; 2017 Aug; 112(6):499-510. PubMed ID: 28580663 [TBL] [Abstract][Full Text] [Related]
17. An economic analysis of costs associated with development of a cell salvage program. Waters JR; Meier HH; Waters JH Anesth Analg; 2007 Apr; 104(4):869-75. PubMed ID: 17377098 [TBL] [Abstract][Full Text] [Related]
18. Is a preoperative group and save necessary for enhanced recovery joint replacement patients? Metcalfe CW; Jayatilaka ML; Cope MR Br J Hosp Med (Lond); 2014 Dec; 75(12):708-10. PubMed ID: 25488535 [TBL] [Abstract][Full Text] [Related]
20. The efficacy, safety and cost-effectiveness of intra-operative cell salvage in high-bleeding-risk cardiac surgery with cardiopulmonary bypass: a prospective randomized and controlled trial. Xie Y; Shen S; Zhang J; Wang W; Zheng J Int J Med Sci; 2015; 12(4):322-8. PubMed ID: 25897293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]